Supportive care in neurooncology

Research output: Contribution to journalArticle

Abstract

Purpose of review: Malignant brain tumors have a very poor prognosis and the natural history of disease is very short, usually less than 1 year. Brain tumor patients often present peculiar symptoms of disease that require appropriate supportive treatment, namely, peritumoral brain edema, venous thromboembolism, seizures and opportunistic infections. On the other hand, some important problems such as rehabilitation, depression, psychological support/communication and end-of-life issues/treatment decisions have been poorly investigated so far. Recent findings: This review focuses on the most recent findings for the management of the most relevant symptoms of brain tumor patients, also discussing the complexity of palliative measures that should be adopted in patients approaching the end of life. Summary: In recent years, there has been some progress in the medical management of brain tumor patients. Nevertheless, much still needs to be done for further improvement, especially focusing on the unmet need for education in supportive care and end-of-life issues.

Original languageEnglish
Pages (from-to)621-626
Number of pages6
JournalCurrent Opinion in Oncology
Volume22
Issue number6
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Brain Neoplasms
Terminal Care
Venous Thromboembolism
Opportunistic Infections
Brain Edema
Seizures
Rehabilitation
Communication
Depression
Psychology
Education
Therapeutics

Keywords

  • brain tumors
  • end-of-life
  • malignant gliomas
  • neurooncology
  • supportive care

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Supportive care in neurooncology. / Pace, Andrea; Metro, Giulio; Fabi, Alessandra.

In: Current Opinion in Oncology, Vol. 22, No. 6, 11.2010, p. 621-626.

Research output: Contribution to journalArticle

Pace, Andrea ; Metro, Giulio ; Fabi, Alessandra. / Supportive care in neurooncology. In: Current Opinion in Oncology. 2010 ; Vol. 22, No. 6. pp. 621-626.
@article{bf5224be46224bffa46309ef44a4ca11,
title = "Supportive care in neurooncology",
abstract = "Purpose of review: Malignant brain tumors have a very poor prognosis and the natural history of disease is very short, usually less than 1 year. Brain tumor patients often present peculiar symptoms of disease that require appropriate supportive treatment, namely, peritumoral brain edema, venous thromboembolism, seizures and opportunistic infections. On the other hand, some important problems such as rehabilitation, depression, psychological support/communication and end-of-life issues/treatment decisions have been poorly investigated so far. Recent findings: This review focuses on the most recent findings for the management of the most relevant symptoms of brain tumor patients, also discussing the complexity of palliative measures that should be adopted in patients approaching the end of life. Summary: In recent years, there has been some progress in the medical management of brain tumor patients. Nevertheless, much still needs to be done for further improvement, especially focusing on the unmet need for education in supportive care and end-of-life issues.",
keywords = "brain tumors, end-of-life, malignant gliomas, neurooncology, supportive care",
author = "Andrea Pace and Giulio Metro and Alessandra Fabi",
year = "2010",
month = "11",
doi = "10.1097/CCO.0b013e32833e078c",
language = "English",
volume = "22",
pages = "621--626",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Supportive care in neurooncology

AU - Pace, Andrea

AU - Metro, Giulio

AU - Fabi, Alessandra

PY - 2010/11

Y1 - 2010/11

N2 - Purpose of review: Malignant brain tumors have a very poor prognosis and the natural history of disease is very short, usually less than 1 year. Brain tumor patients often present peculiar symptoms of disease that require appropriate supportive treatment, namely, peritumoral brain edema, venous thromboembolism, seizures and opportunistic infections. On the other hand, some important problems such as rehabilitation, depression, psychological support/communication and end-of-life issues/treatment decisions have been poorly investigated so far. Recent findings: This review focuses on the most recent findings for the management of the most relevant symptoms of brain tumor patients, also discussing the complexity of palliative measures that should be adopted in patients approaching the end of life. Summary: In recent years, there has been some progress in the medical management of brain tumor patients. Nevertheless, much still needs to be done for further improvement, especially focusing on the unmet need for education in supportive care and end-of-life issues.

AB - Purpose of review: Malignant brain tumors have a very poor prognosis and the natural history of disease is very short, usually less than 1 year. Brain tumor patients often present peculiar symptoms of disease that require appropriate supportive treatment, namely, peritumoral brain edema, venous thromboembolism, seizures and opportunistic infections. On the other hand, some important problems such as rehabilitation, depression, psychological support/communication and end-of-life issues/treatment decisions have been poorly investigated so far. Recent findings: This review focuses on the most recent findings for the management of the most relevant symptoms of brain tumor patients, also discussing the complexity of palliative measures that should be adopted in patients approaching the end of life. Summary: In recent years, there has been some progress in the medical management of brain tumor patients. Nevertheless, much still needs to be done for further improvement, especially focusing on the unmet need for education in supportive care and end-of-life issues.

KW - brain tumors

KW - end-of-life

KW - malignant gliomas

KW - neurooncology

KW - supportive care

UR - http://www.scopus.com/inward/record.url?scp=77958508436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958508436&partnerID=8YFLogxK

U2 - 10.1097/CCO.0b013e32833e078c

DO - 10.1097/CCO.0b013e32833e078c

M3 - Article

C2 - 20706120

AN - SCOPUS:77958508436

VL - 22

SP - 621

EP - 626

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 6

ER -